ArticleTherapeutic advances in medical oncology2022
AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib
Aditya Bardia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it